Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors

Abstract

The genetic nature of testicular germ cell tumors and the molecular mechanisms underlying the morphological and clinical differences between the two subtypes, seminomas and nonseminomas, remains unclear. Genetic studies show that both subtypes exhibit many of the same regional genomic disruptions, although the frequencies vary and few clear differences are found. We demonstrate significant epigenetic differences between seminomas and nonseminomas by restriction landmark genomic scanning. Seminomas show almost no CpG island methylation, in contrast to nonseminomas that show CpG island methylation at a level similar to other solid tumors. We find an average of 1.11% of CpG islands methylation in nonseminomas, but only 0.08% methylated in seminomas. Furthermore, we demonstrate that seminomas are more highly hypomethylated than nonseminomas throughout their genome. Since both subtypes are thought to arise from primordial germ cells, the epigenetic differences seen between these subtypes may reflect the normal developmental switch in primordial germ cells from an undermethylated genome to a normally methylated genome. We discuss these findings in relation to different developmental models for seminomatous and nonseminomatous testicular germ cell tumors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG . 2001 Hum. Mol. Genet. 10: 687–692

  • Bestor TH . 1998 Am. J. Hum. Genet. 62: 1269–1273

  • Chaganti RS, Houldsworth J . 1998 Apmis 106: 80–83 discussion 83–84

  • Coffigny H, Bourgeois C, Ricoul M, Bernardino J, Vilain A, Niveleau A, Malfoy B, Dutrillaux B . 1999 Cytogenet. Cell Genet. 87: 175–181

  • Costello JF, Fruhwald MC, Smiraglia D, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C . 2000 Nat. Genet. 24: 132–138

  • Costello JF, Plass C . 2001 J. Med. Genet. 38: 285–303

  • Dai Z, Lakshmanan RR, Zhu WG, Smiraglia D, Rush LJ, Fruhwald MC, Brena RM, Li B, Wright FA, Ross P, Otterson GA, Plass C . 2001 Neoplasia 3: 314–323

  • Davis TL, Trasler JM, Moss SB, Yang GJ, Bartolomei MS . 1999 Genomics 58: 18–28

  • Faulkner SW, Leigh DA, Oosterhuis JW, Roelofs H, Looijenga LH, Friedlander ML . 2000 Br. J. Cancer 83: 729–736

  • Fruhwald MC, O'Dorisio MS, Dai Z, Tanner SM, Balster DA, Gao X, Wright FA, Plass C . 2001 Oncogene 20: 5033–5042

  • Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M . 1983 Nucleic Acids Res. 11: 6883–6894

  • Jones PA . 2001 Nature 409: 141 143–144

  • Looijenga LH, Gillis AJ, van Gurp RJ, Verkerk AJ, Oosterhuis JW . 1997 Am. J. Pathol. 151: 581–590

  • Looijenga LH, Gillis AJ, Van Putten WL, Oosterhuis JW . 1993 Lab. Invest. 68: 211–219

  • Looijenga LH, Verkerk AJ, Dekker MC, van Gurp RJ, Gillis AJ, Oosterhuis JW . 1998 Apmis 106: 187–195 discussion 196–197

  • Lutzker SG, Barnard NJ . 1998 Mol. Med. Today 4: 404–411

  • Murty VV, Chaganti RS . 1998 Semin. Oncol. 25: 133–144

  • Ng HH, Bird A . 1999 Curr. Opin. Genet. Dev. 9: 158–163

  • Oosterhuis JW, Castedo SM, de Jong B, Cornelisse CJ, Dam A, Sleijfer DT, Schraffordt Koops H . 1989 Lab. Invest. 60: 14–21

  • Ottesen AM, Kirchhoff M, De-Meyts ER, Maahr J, Gerdes T, Rose H, Lundsteen C, Petersen PM, Philip J, Skakkebaek NE . 1997 Genes Chromosomes Cancer 20: 412–418

  • Peltomaki P . 1991 Biochim. Biophys. Acta 1096: 187–196

  • Peltomaki P, Alfthan O, de la Chapelle A . 1991 Br. J. Cancer 63: 851–858

  • Pogribny I, Yi P, James SJ . 1999 Biochem. Biophys. Res. Commun. 262: 624–628

  • Rajpert-De Meyts E, Jorgensen N, Brondum-Nielsen K, Muller J, Skakkebaek NE . 1998 Apmis 106: 198–204 discussion 204–206

  • Rajpert-De Meyts E, Kvist M, Skakkebaek NE . 1996 Virchows Arch. 428: 133–139

  • Rorth M, Rajpert-De Meyts E, Andersson L, Dieckmann KP, Fossa SD, Grigor KM, Hendry WF, Herr HW, Looijenga LH, Oosterhuis JW, Skakkebaek NE . 2000 Scand. J. Urol. Nephrol. Suppl. 205 166–186

  • Rush LJ, Dai Z, Smiraglia D, Gao X, Wright FA, Fruhwald M, Costello JF, Held WA, Yu L, Krahe R, Kolitz JE, Bloomfield CD, Caligiuri MA, Plass C . 2001 Blood 97: 3226–3233

  • Skakkebaek NE, Rajpert-De Meyts E, Jorgensen N, Carlsen E, Petersen PM, Giwercman A, Andersen AG, Jensen TK, Andersson AM, Muller J . 1998 Apmis 106: 3–11 discussion 12

  • Smiraglia D, Frühwald MC, Costello JF, McCormick SP, Dai Z, Peltomäki P, MS OD, Cavenee WK, Plass C . 1999 Genomics 58: 254–262

  • Summersgill B, Goker H, Osin P, Huddart R, Horwich A, Fisher C, Shipley J . 1998 Diagn. Mol. Pathol. 7: 260–266

  • Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP . 1999 Proc. Natl. Acad. Sci. USA 96: 8681–8686

  • Toyota M, Ohe-Toyota M, Ahuja N, Issa JP . 2000 Proc. Natl. Acad. Sci. USA 97: 710–715

  • Trasler JM . 1998 Semin. Cell. Dev. Biol. 9: 467–474

Download references

Acknowledgements

We thank Dr Laura Rush for critical reading of the manuscript. We thank Drs Jill James and Igor Pogribny for consultation concerning the cytosine extension assay. We thank Dr Fred Wright and Sandya Liyanarachchi for assistance with statistical analysis. We thank Julia Hall and Yue-Zhong Wu for technical assistance. This work was supported in part by grant P30CA16058, National Cancer Institute, Bethesda, MD, USA. DJ Smiraglia was supported in part by grant T32 CA09338-20, National Cancer Institute, Bethesda, MD, USA. SM Kraggerud and RA Lothe were supported by grants from the Norwegian Cancer Society.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dominic J Smiraglia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smiraglia, D., Szymanska, J., Kraggerud, S. et al. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene 21, 3909–3916 (2002). https://doi.org/10.1038/sj.onc.1205488

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205488

Keywords

This article is cited by

Search

Quick links